Yahoo Canada Web Search

Search results

      • Nano-X is a risky buy even if its technology does exist, because it's still in its very early growth stages. The best way to prove there's demand for a product and that it will sell, is through, well, sales. And Nano-X isn't there yet.
      www.fool.com/investing/2020/10/18/is-nano-x-the-ultimate-contrarian-buy/
  1. People also ask

  2. Oct 2, 2021 · Israeli technology company Nano-X Imaging(NNOX -1.84%) says its low-cost X-ray machine and razor-and-blades business model could revolutionize the field of radiology. But investing in breakthrough...

  3. Feb 29, 2024 · According to a recent regulatory filing, chipmaker (NASDAQ: NVDA) now owns a stake in (NASDAQ: NNOX), a small Israeli medical device company that makes X-ray machines. While the investment was...

  4. Feb 29, 2024 · According to a recent regulatory filing, chipmaker Nvidia (NVDA 1.99%) now owns a stake in Nano-X Imaging (NNOX 1.76%), a small Israeli medical device company that makes X-ray machines.

  5. Mar 11, 2021 · Nano-X Imaging Could Be Teaming Up With Nvidia, and Its Stock Is Flying. Can It Continue?

    • Taylor Carmichael
  6. Feb 27, 2024 · Nvidia's investment in Nano-X is accidental and insignificant, with only 60,000 shares worth $400,000. See why there is no compelling reason to own NNOX stock.

  7. Feb 16, 2024 · Nano-X Imaging's revenue and profitability remain poor, with negative bottom line results. Find out why I rate NNOX stock a sell.

  8. Jul 2, 2021 · Even if Nano-X has difficulty in its manufacturing, its technology would make it a worthwhile takeover target for the legacy companies that make digital imaging machines, such as Fujifilm...